Ungated Archives | ArisGlobal

Gain the Decision Advantage

Breakthrough 2027 brings together life sciences leaders, industry regulators and experts, to explore the future of AI in life sciences.

Accelerating End-to-End Safety Assessment Across Fragmented Data with Signals Agents

Transforming Regulatory Operations with AI: Why Frost & Sullivan Recognized ArisGlobal as a Visionary Leader

Transform Regulatory Affairs with AI Innovation

Learn how our industry-leading LifeSphere Regulatory platform, powered by NavaX™ AI is helping life sciences organizations drive unprecedented time and cost savings in Regulatory Affairs, while maintaining consistent global regulatory compliance.

Modernizing Safety Operations with AI: How Bristol Myers Squibb Achieved 25% Efficiency Gains in PV Case Intake and Processing

ReporterX Fact Sheet

Learn how ReporterX, powered by NavaX, serves as an intelligent front-end patient data collection application, enabling reporters across the globe to leverage AI-assisted capabilities.

Regulatory Intelligence Fact Sheet

Transform literature monitoring with our system-agnostic, GenAI-powered solution.

Video – Advancing Signal Detection with GenAI

Webinar – Accelerating Literature Monitoring with GenAI Technology

Future-Proof Your Regulatory Compliance: Critical Insights for 2025 and Beyond

Document Distribution Fact Sheet

Document Distribution simplifies your global drug safety and safety reporting operations by making it quick and easy to distribute safety reports to key stakeholder groups.

ArisGlobal is a pivotal partner in the life sciences industry, specializing in solutions that drive drug development, safety monitoring, and regulatory compliance. We collaborate with more than 220 global life sciences companies, CROs, and government health authorities, including leading biopharmaceutical firms and regulatory bodies such as FDA, Health Canada, and NMPA.

Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.